Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jake Jacobs

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Sexually Transmitted Diseases|July 26, 2005
Cost-effectiveness of hepatitis A/B vaccination in the private sectorR Jake Jacobs, Allen S Meyerhoff
Sexually Transmitted Diseases|November 7, 2003
Cost-effectiveness of hepatitis A/B vaccine versus hepatitis B vaccine in public sexually transmitted disease clinicsR Jake Jacobs, Allen S Meyerhoff
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 20, 2004
Effect of middle school entry requirements on hepatitis B vaccination coverageR Jake Jacobs, Allen S Meyerhoff
Vaccine|March 9, 2004
Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmatesR Jake Jacobs, Philip Rosenthal, Allen S Meyerhoff
Journal of American College Health : J of ACH|September 27, 2003
The cost effectiveness of hepatitis immunization for US college studentsR Jake Jacobs, Sammy Saab, Allen S Meyerhoff
Digestive Diseases and Sciences|August 23, 2005
Immunization needs of chronic liver disease patients seen in primary care versus specialist settingsR Jake Jacobs, Allen S Meyerhoff, Sammy Saab
Clinical Pediatrics|October 8, 2005
Hepatitis A immunization strategies: universal versus targeted approachesR Jake Jacobs, Allen S Meyerhoff, Thomas Zink
Infection Control and Hospital Epidemiology|August 11, 2004
Cost-effectiveness of hepatitis A-B vaccine versus hepatitis B vaccine for healthcare and public safety workers in the western United StatesR Jake Jacobs, Gene A Gibson, Allen S Meyerhoff
Journal of Travel Medicine|September 22, 2006
Hepatitis B risks and immunization coverage among American travelersBradley A Connor, R Jake Jacobs, Allen S Meyerhoff
Pharmacoeconomics|August 31, 2002
Valuation of symptomatic hepatitis a in adults: estimates based on time trade-off and willingness-to-pay measurementR Jake Jacobs, Ronald J Moleski, Allen S Meyerhoff
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Sexually Transmitted Diseases|July 26, 2005
Cost-effectiveness of hepatitis A/B vaccination in the private sectorR Jake Jacobs, Allen S Meyerhoff
Sexually Transmitted Diseases|November 7, 2003
Cost-effectiveness of hepatitis A/B vaccine versus hepatitis B vaccine in public sexually transmitted disease clinicsR Jake Jacobs, Allen S Meyerhoff
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 20, 2004
Effect of middle school entry requirements on hepatitis B vaccination coverageR Jake Jacobs, Allen S Meyerhoff
Vaccine|March 9, 2004
Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmatesR Jake Jacobs, Philip Rosenthal, Allen S Meyerhoff
Journal of American College Health : J of ACH|September 27, 2003
The cost effectiveness of hepatitis immunization for US college studentsR Jake Jacobs, Sammy Saab, Allen S Meyerhoff
Digestive Diseases and Sciences|August 23, 2005
Immunization needs of chronic liver disease patients seen in primary care versus specialist settingsR Jake Jacobs, Allen S Meyerhoff, Sammy Saab
Clinical Pediatrics|October 8, 2005
Hepatitis A immunization strategies: universal versus targeted approachesR Jake Jacobs, Allen S Meyerhoff, Thomas Zink
Infection Control and Hospital Epidemiology|August 11, 2004
Cost-effectiveness of hepatitis A-B vaccine versus hepatitis B vaccine for healthcare and public safety workers in the western United StatesR Jake Jacobs, Gene A Gibson, Allen S Meyerhoff
Journal of Travel Medicine|September 22, 2006
Hepatitis B risks and immunization coverage among American travelersBradley A Connor, R Jake Jacobs, Allen S Meyerhoff
Pharmacoeconomics|August 31, 2002
Valuation of symptomatic hepatitis a in adults: estimates based on time trade-off and willingness-to-pay measurementR Jake Jacobs, Ronald J Moleski, Allen S Meyerhoff
Pageof 2